Agne Paner to Biomarkers, Tumor
This is a "connection" page, showing publications Agne Paner has written about Biomarkers, Tumor.
Connection Strength
0.043
-
Patient-reported outcomes in relapsed/refractory multiple myeloma treated with melflufen plus dexamethasone: analyses from the Phase II HORIZON study. Br J Haematol. 2022 02; 196(3):639-648.
Score: 0.043